The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in
Wuhan, China in late 2019, and its resulting coronavirus disease, COVID-19, was declared a …

Lack of evidence on SARS-CoV-2 transmission dynamics has led to shifting isolation
guidelines between airborne and droplet isolation precautions. During the initial isolation of 13 …

Background. There is limited information on compliance rates with anti-vectorial protective
measures (AVPMs) during travel to countries with risk of dengue and chikungunya. We …

Background: The contribution of multi-drug–resistant gram-negative bacilli infections (MDRGN-I)
in patients with trauma is not well described. We present characteristics of MDRGN-Is …

Introduction All Department of Defense (DoD) guidance documents recommend cefazolin or
clindamycin as post-trauma antibiotic prophylaxis for open soft-tissue injuries. Although not …

The Trauma Infectious Disease Outcomes Study began in June 2009 as combat operations
were decreasing in Iraq and increasing in Afghanistan. Our analysis examines the rate of …

BACKGROUND We examined combat-related open extremity fracture infections as a function
of whether posttrauma antimicrobial prophylaxis included expanded Gram-negative (EGN) …

Background Infectious complications related to deployment trauma significantly contribute
to the morbidity and mortality of wounded service members. The Trauma Infectious Disease …

Background Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that was first discovered in …

The optimal time to initiate research on emergencies is before they occur. However, timely
initiation of high-quality research may launch during an emergency under the right conditions. …